RxDoctor Payments Data

Jorge Casas, MD

Orthopaedic Surgery · Dallas, TXNPI 1013951110

Payments from drug & device makers

$209,580in general payments, 2019–2025

Across 79 payments — averaging $2652.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Onkos Surgical, Inc.$193K
  • Biocomposites Inc$16K
  • Linkbio Corp$372
  • Johnson & Johnson$270
  • Restor3d, Inc.$162
  • Wound Management Technologies, Inc$113
  • plus $167 from 4 others

What the payments were for

  • Royalty or licence$171,17582%
  • Consulting fees$32,35015%
  • Travel & lodging$2,6291%
  • Food & beverage$3,4262%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Onkos Surgical, Inc.62$192,896
Biocomposites Inc1$15,600
Linkbio Corp2$372
Johnson & Johnson(2 entities)5$270
Restor3d, Inc.1$162
Wound Management Technologies, Inc1$113
Ossur Americas, Inc.4$91
Stryker1$36
Pylant Medical1$25
Medical Device Business Services, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$209,580 in reported general payments places this provider in the 90th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$111,550
Medicare patients
131
Services billed
426

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →